Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

Labcorp Holdings Inc. , a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July ...

LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.

Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and ...

Good day, and thank you for standing by. Welcome to the Q1 2026 Labcorp Holdings Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams act quickly when every second counts Fentanyl Urine Visual Test is ...

Technology vendors continue to develop advanced artificial intelligence for patient care and diagnostics, several with recently announced new enhancements. Of note, we highlight software that maps ...

Labcorp has closed a deal to buy assets from Crouse Health’s pathology reference laboratory, the company said Thursday. As well as completing the acquisition of assets from Crouse’s Laboratory ...